Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utilization of Newly Approved Oncology Medications in Middle Eastern Population

NCT02783885 is registered in ClinicalTrials.gov with National Guard Health Affairs as lead sponsor.

NCT NCT02783885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utilization of Newly Approved Oncology Medications in Middle Eastern Population
Lead sponsor
National Guard Health Affairs
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2016
Completion date
September 30, 2020
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer